跳至主要内容
临床试验/CTRI/2021/09/037013
CTRI/2021/09/037013招募中未知

A prospective, observational, open label study to evaluate efficacy and safety of Anidulafungin in comparison to Caspofungin in Invasive Candida infections in India (ADVANCE)

Dr Yatin Mehta0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients of either sex with age =18 years with a confirmed cases of Invasive Candida infection.
  • 2. Patients who will be able to provide the informed consent.
  • 3. Patients prescribed with Caspofungin or Anidulafungin

排除标准

  • 1. Patients of either sex with age less than 18 years.
  • 2. Patients with aspergillus or any other mold or yeast [Cryptococcus] infections.
  • 3. Patients on Micafungin or other antifungal agents.
  • 4. Pregnant or breast-feeding women

研究者

发起方
Dr Yatin Mehta

相似试验

An Investigator initiated study comparing of two... | 临床试验